Dr. Brian Furukawa, MD
What this data tells you about Dr. Furukawa
Dr. Brian Furukawa is a pulmonary disease in Temple, TX, with 18 years in practice. Based on federal Medicare data, Dr. Furukawa performed 799 Medicare services across 615 unique beneficiaries.
Between the years covered by Open Payments, Dr. Furukawa received a total of $162,471 from 16 pharmaceutical and/or device companies across 212 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Furukawa is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 152 | $71 | $209 |
| Hospital follow-up visit, high complexity | 137 | $90 | $201 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 55 | $26 | $929 |
| Critical care, first 30-74 min | 55 | $163 | $535 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 50 | $9 | $86 |
| Hospital follow-up visit, moderate complexity | 41 | $61 | $139 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 40 | $64 | $1,123 |
| New patient office visit, complex (60-74 min) | 40 | $131 | $399 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 29 | $116 | $1,797 |
| Office visit, established patient, complex (40-54 min) | 27 | $108 | $280 |
| Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | 26 | $50 | $833 |
| Aspiration of fluid from chest cavity using imaging guidance | 23 | $84 | $2,075 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 21 | $72 | $3,932 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 21 | $126 | $2,630 |
| Initial hospital admission, moderate complexity | 20 | $100 | $267 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | 17 | $179 | $2,630 |
| Office visit, established patient (20-29 min) | 17 | $44 | $142 |
| Initial hospital admission, high complexity | 16 | $135 | $392 |
| Biopsy of lobe of lung using an endoscope, each additional lobe | 12 | $37 | $213 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (66%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 3% for pulmonary disease in TX.
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Furukawa is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 3%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Furukawa experienced with office visit, established patient (30-39 min)?
Does Dr. Furukawa receive payments from pharmaceutical companies?
How do Dr. Furukawa's costs compare to other pulmonary diseases in Temple?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology